Dr. David Baidal, MD

Dr. Baidal practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Baidal's NPI, 1487896643, was assigned on April 1, 2009. Dr. Baidal graduated from Universidad Catolica de Santiago de Guayaquil in 2000. Dr. Baidal holds Florida license ME124485.

Dr. Baidal's primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Baidal's primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Baidal is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baidal practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Baidal's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Baidal is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Baidal's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists chronic diabetes, diabetic emergency, high cholesterol and underactive thyroid among the conditions Dr. Baidal treats.

CMS data shows 189 Medicare services from Dr. Baidal across 8 procedure codes in 2024, for 83 Medicare patients. Medicare paid $10,253 for them.

CMS counts 83 Medicare patients who saw Dr. Baidal in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have diabetes, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baidal's median patient age at 54, with 67% women.

In 2024, Dr. Baidal wrote 670 Medicare Part D claims for 103 patients. 43% of them were for generic drugs. CMS names the drug for 501 of them, across 20 drugs with 11 or more claims each, at $235,100 in total drug cost. In 2023, CMS named 476 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Baidal for performance year 2024, reported as part of a group. Dr. Baidal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baidal as offering telehealth.

Dmand AI links 64 papers to Dr. Baidal, published from 2005 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1 and Blood Glucose. Dr. Baidal has published most often in Transplantation. Dr. Baidal's most frequent co-authors are Rodolfo Alejandro, Camillo Ricordi, MD and Raquel N. Faradji, MD.

Dmand AI links Dr. Baidal to 5 clinical trials, 3 of them phase 1/2 studies. 3 are still active or recruiting. Conditions studied include Diabetes Mellitus, Type 1, Hypoglycemia and Autoimmune Diseases. Rodolfo Alejandro sponsors the most, 2.

CMS Open Payments shows 53 general payments to Dr. Baidal from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Vertex Pharmaceuticals Incorporated paid the most, $4,833. It also lists 1 research payment totaling $2,091 in 2023.

Dr. Baidal graduated from Universidad Catolica de Santiago de Guayaquil in 2000.

Dr. Baidal is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.